Uploads Contact
/
Login Upload

  • Search Results for 'Topics In Clinical Trials 2'

New Policies Needed to Reduce the Global Burden of
New Policies Needed to Reduce the Global Burden of
debby-jeon
R&D Blueprint : p latform technologies to improve control of severe infectious diseases
R&D Blueprint : p latform technologies to improve control of severe infectious diseases
faustina-dinatale
[Current Medical Practitioner (1962), 7, 381]
[Current Medical Practitioner (1962), 7, 381]
tatiana-dople
Introduction Heart failure HF is a common cardiovascul
Introduction Heart failure HF is a common cardiovascul
conchita-marotz
Biomarkers in Phase II designs in cancer clinical trials
Biomarkers in Phase II designs in cancer clinical trials
conchita-marotz
Precision Oncology Carolyn M. Hutter, PhD
Precision Oncology Carolyn M. Hutter, PhD
lindy-dunigan
Biomedical research methods
Biomedical research methods
giovanna-bartolotta
www.topra.orgRegulatory Rapporteur – Vol 7, No 11, November 2010
www.topra.orgRegulatory Rapporteur – Vol 7, No 11, November 2010
pasty-toler
Reliably basing conclusions on
Reliably basing conclusions on
faustina-dinatale
Multi-centre trials in Orthopaedic Oncology:
Multi-centre trials in Orthopaedic Oncology:
phoebe-click
Consider Clinical Trials as treatment options for eligible patients. .
Consider Clinical Trials as treatment options for eligible patients. .
tatyana-admore
REVIEW Open Access Chimeric antigen receptor for adopt
REVIEW Open Access Chimeric antigen receptor for adopt
trish-goza
In addition, Section 2221 would allow companies to make changes to eve
In addition, Section 2221 would allow companies to make changes to eve
jane-oiler
OCTOBER 2015BUCHAREST, ROMANIAOUTSOURCING CLINICAL TRIALS INEMERGING E
OCTOBER 2015BUCHAREST, ROMANIAOUTSOURCING CLINICAL TRIALS INEMERGING E
cheryl-pisano
Letter to the Editor Selection bias allocation concealment and randomization design in
Letter to the Editor Selection bias allocation concealment and randomization design in
luanne-stotts
An update on clinical trials and
An update on clinical trials and
celsa-spraggs
Exploration of Endpoints for Pivotal Clinical Trials to Tre
Exploration of Endpoints for Pivotal Clinical Trials to Tre
yoshiko-marsland
OMICS International welcomes submissions that are original and technically so as to
OMICS International welcomes submissions that are original and technically so as to
briana-ranney
Level Control Level Level Level Number of trials Number of trials Number of trials
Level Control Level Level Level Number of trials Number of trials Number of trials
ellena-manuel
Pharmacogenetics
Pharmacogenetics
olivia-moreira
Insights from clinical trials
Insights from clinical trials
min-jolicoeur
Investigator
Investigator
liane-varnes
ROAD MAP: Getting a Cancer Study Done at Jefferson
ROAD MAP: Getting a Cancer Study Done at Jefferson
ellena-manuel
NIDA’s Clinical Trials Network:
NIDA’s Clinical Trials Network:
conchita-marotz